Bio-IT World January 27, 2026
BigHat Biosciences and Revvity have entered collaborations with Eli Lilly and Company; Immunai has signed an agreement with Bristol Myers Squibb; SandboxAQ launches a new AI model; and more.
Noetik announced a five-year strategic collaboration and AI model licensing agreement with GSK. The partnership provides GSK’s AI and Therapeutics teams with a direct, non-exclusive license to access Noetik’s OCTO-VC virtual cell foundation models in non-small cell lung cancer and colorectal cancer. The collaboration combines GSK’s leadership in AI and tumor immunology with Noetik’s industry-first virtual cell simulation technology to accelerate the development of novel medicines. Additionally, the companies will collaborate to generate bespoke human spatial datasets, applying human-first biological simulation to areas of strategic interest. Press release.
...Today's Sponsors
Today's Sponsor